Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons

Journal of Neuroscience

Volumn 18, Issue 13, 1998, Pages 5068-5077

  Moore, Holly ^a   Todd, Christopher L ^a   Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic drugs; Baclofen; Depolarization block; Dopamine; Haloperidol; Microdialysis; Schizophrenia; Single unit recording; Striatum; Substantia nigra

Indexed keywords

BACLOFEN; DOPAMINE; DOPAMINE RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; DEPOLARIZATION; DOPAMINE BRAIN LEVEL; MICRODIALYSIS; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SINGLE UNIT ACTIVITY; SUBSTANTIA NIGRA;

EID: 0032125226     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-13-05068.1998     Document Type: Article

References (76)

1. Albe-Fessard D, Sanderson P (1987) A demonstration of tonic inhibitory and facilitatory striatal actions on substantia nigra neurons. Adv Behav Biol 32:321-326.
2. Arnt J, Skarsfeldt T (1998) Do novel antipsychotics have similar pharmacological characteristics? A review of evidence. Neuropsychopharmacology 18:63-101.
3. Asin KE, Wirtshafter D (1990) Evidence for dopamine involvement in reinforcement obtained using a latent extinction paradigm. Pharmacol Biochem Behav 36:417-420.
4. Benveniste H (1989) Brain microdialysis. J Neureichem 52:1667-1679.
5. Benveniste H, Drejer J, Schousboe A, Diemer NH (1987) Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus of the rat. J Neurochem 49:729-734.
6. Biggio G, Casu M, Klimek V, Cessa L (1980) Dopamine synthesis: tolerance to haloperidol and supersensitivity to apomorphine depend on presynaptic receptors. Adv Biochem Psychopharmaeol 24:17-22.
7. Bolam JP, Smith Y (1990) The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat. Brain Res 529:57-78.
8. Braszko JJ, Bannon MJ, Bunney BS, Roth RH (1981) Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity. J Pharmacol Exp Ther 216:289-293.
9. Bunney BS, Grace AA (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715-1728.
10. Chesi AJR, Feasey-Truger KJ, Alzheimer C, Bruggencate GT (1995) Dopamine autoreceptor sensitivity is unchanged in rat nucleus accumbens after chronic haloperidol treatment: an in vivo and in vitro voltammetric study. Eur J Neurosci 7:2450-2457.
11. Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607-1619.
12. Collingridge GL, Davies J (1981) The influence of striatal stimulation and putative neurotransmitters on identified neurones in the rat substantia nigra. Brain Res 212:345-359.
13. Darlington RB (1990) Regression and linear models. New York: McGraw-Hill.
14. Dykstra KH, Hsiao JK, Morrison PF, Bungay PM, Mefford IN, Scully MM, Dedrick RL (1992) Quantitative examination of tissue concentration profiles associated with microdialysis. J Neurochem 58:931-940.
15. Egan MF, Chrapusta S, Karoum F, Lipska BK, Wyatt RJ (1996) Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine. J Neural Transm 103:777-805.
16. Essig EC, Kilpatrick IC (1991) Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex, and amygdala. Psychopharmacology (Berl) 104:194-200.
17. Feasey-Truger KJ, Earl CD, Alzheimer C, Bruggencate GT (1995) Stimulus-evoked dopamine overflow in the rat nucleus accumbens is decreased following chronic haloperidol administration: an in vivo voltammetric study. Neurosci Lett 183:91-95.
18. Gale K, Hong JS, Guidotti A (1977) Presence of substance P and GABA in separate striatonigral neurons. Brain Res 136:371-375.
19. Georgieva J, Luthman J, Mohringe B, Magnusson O (1993) Tissue and microdialysate changes after repeated and permanent probe implantation in the striatum of freely moving rats. Brain Res Bull 31:463-470.
20. Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24.
21. Grace AA (1992) The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. J Neural Transm [Suppl] 36:91-131.
22. Grace AA, Bunney BS (1980) Effects of baclofenon nigral dopaminergic cell activity following acute and chronic haloperidol treatment. Brain Res Bull [Suppl] 5:537-543.
23. Grace AA, Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons. 1. Identification and characterization. Neuroscience 10:301-315.
24. Grace AA, Bunney BS (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877-2890.
25. Grace AA, Bunney BS (1985) Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res 333:271-284.
26. Grace AA, Bunney BS (1986) Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther 238:1092-1100.
27. Grace A A, Bunney BS, Moore H, Todd CL (1997) Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci 20:31-37.
28. Hammond EO, Torok ML, Ettenberg A (1991) Different patterns of behavior produced by haloperidol, pentobarbital, and dantrolene in tests of unconditioned locomotion and operant responding. Psychopharmacology (Berl) 104:150-156.
29. Harrow M, Yonan CA, Sands JR, Marengo J (1994) Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved? Schizophrenia Bull 20:327-338.
30. Hernandez L, Hoebel BG (1989) Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Brain Res Bull 22:763-769.
31. Hoebel BG, Hernandez L, Schwartz DH, Mark GP, Hunter GA (1989) Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications. Ann NY Acad Sci 575:171-191.
32. Horvitz JC, Ettenberg A (1988) Haloperidol blocks the responsereinstating effects of food reward: a methodology for separating neuroleptic effects on reinforcement and motor processes. Pharmacol Biochem Behav 31:861-865.
33. Ichikawa J, Meltzer HY (1990) Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment, Brain Res 507:138-142.
34. Ichikawa J, Meltzer H Y (1991) Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and nucleus accumbens. J Pharmacol Exp Ther 256:348-357.
35. Ichikawa J, Meltzer HY (1992) The effect of chronic atypical antipsy- chotic drugs and haloperidol on amphetamine-induced dopamine release in vivo. Brain Res 574:98-104.
36. 1 receptors and their desensitization after chronic treatment. Eur J Pharmacol 264:55-60.
37. Invernizzi R, Morali F, Pozzi L, Samanin R (1990) Effects of acute and chronic elozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats. Br J Pharmacol 100:774-778.
38. King D, Zigmond MJ, Finlay JM (1997) Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extra-cellular dopamine in the nucleus accumbens core and shell. Neuroscience 77:141-153.
39. Klitenic MA, Taber MT, Fibiger HC (1996) Effects of chronic haloperidol on stress and stimulation-induced increased in dopamine release: tests of the depolarization block hypothesis. Neuropsychopharmacology 15:424-428.
40. Lane RF, Blaha CD (1987) Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. Brain Res Bull 18:135-183.
41. Lappalainen J, Hietala J, Koulu M, Seppala T, Sjoholm B, Syvalahti E (1990) Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain. J Pharmacol Exp Ther 252:845-852.
42. Mas M, Fumero B, Gonzalez-Mora JL (1995) Voltammetric and microdialysis monitoring of brain monoamine neurotransmitter release during sociosexual interactions. Behav Brain Res 71:69-79.
43. Matsumoto T, Uchimura H, Hirano M, Kim JL, Yokoo HA, Shimomura M, Nakahara T, Inoue K, Oomagari K (1983) Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain. Eur J Pharmacol 89:27-33.
44. Mereu G, Lilliu V, Vargiu P, Muntoni AL, Diana M, Gessa GL (1995) Depolarization inactivation of dopamine neurons: an artifact? J Neurosci 15:1144-1149.
45. Mirenowicz J, Schultz W (1994) Importance of unpredictability for reward responses in primate dopamine neurons. J Neurophysiol 72:1024-1027.
46. Mirenowicz J, Schultz W (1996) Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 379:449-451.
47. Moghaddam B, Bunney BS (1993) Depolarization inactivation of dopamine neurons: terminal release characteristics. Synapse 14:195-200.
48. Morgan ME, Singhal D, Anderson BD (1996) Quantitative assessment of blood-brain barrier damage during microdialysis. J Pharmacol Exp Ther 277:1167-1176.
49. Murase S, Grenoff J, Chouvet G, Gonon FG, Svennson T (1993) Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett 157:53-56.
50. Nissbrandt N, Elverfors A, Engberg G (1994) Pharmacologically induced cessation of burst activity in nigral neurons: significance for the terminal dopamine efflux. Synapse 17:217-224.
51. Osborne PG, O'Connor WT, Ungerstedt U (1991) Effect of varying the ionic concentration of a microdialysis perfusate on basal striatal dopamine levels in awake rats. J Neurochem 56:452-456.
52. Osborne PG, O'Conner WT, Beck O, Ungerstedt U (1994) Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release. Brain Res 634:20-30.
53. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. San Diego: Academic.
54. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. San Diego: Academic.
55. Racagni G, Bruno F, Bugatti A, Parenti M, Apud JA, Santini V, Carenzi A, Groppetti A, Cattabeni F (1980) Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment. Adv Biochem Psychopharmacol 24:45-52.
56. Rastogi RB, Rastogi SK, Lapierre YD, Singhal RL (1982) Bromocriptine-induced changes in dopamine and gamma aminobutyric acid in haloperidol withdrawn rats. Prog Neuro-Psychopharmacol Biol Psychiatry 6:443-447.
57. Salamone JD, Steinpreis RE, McCullough LD, Smith P, Grebel D, Mahan K (1991) Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl) 104:515-521.
58. Santiago M, Westerink BHC (1992) The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: a dual-probe microdialysis study in awake rats. Eur J Pharmacol 219:175-181.
59. Santiago M, Machado A, Cano J (1993) In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen. Br J Pharmacol 109:814-818.
60. See RE (1993) Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia. Neuropsychopharmacology 9:101-109.
61. See RE, Kalivas PW (1996) Tolerance and sensitization to the effects of antipsychotic drugs on dopamine transmission. In: Antipsychotics (Czernansky JG, ed), pp 203-224. Berlin: Springer.
62. See RE, Murray CE (1992) Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats. Neurosci Lett 142:100-104.
63. See RE, Chapman MA, Murray CE, Aravagiri M (1992) Regional differences in chronic neuroleptic effects on extracellular dopamine activity. Brain Res Bull 29:473-478.
64. Shuaib A, Xu K, Crain B, Siren AL, Feuerstein G, Hallenbeck J, Davis JN (1990) Assessment of damage from implantation of microdialysis probes in the rat hippocampus with silver degeneration staining. Neurosci Lett 112:149-154.
65. Taber MT, Fibiger HC (1997) Feeding-evoked dopamine release in the nucleus accumbens: regulation by glutamatergic mechanisms. Neuroscience 76:1105-1112.
66. Todd CL, Moore H, Harden DG, Grace AA (1996) Microdialysis probe implantation into striatum disrupts haloperidol-induced dopamine cell depolarization block. Soc Neurosci Abstr 22:359.
67. Todd CL, Moore H, Grace AA (1997) Repeated haloperidol treatment reduces basal dopamine efflux in striatum and the number of spontaneously-firing dopamine cells in the substantia nigra. Soc Neurosci Abstr 23:403.
68. Tulloch IF, Arbuthnott GW, Wright AK (1978) Topographical organization of the striatonigral pathway revealed by anterograde and retrograde neuroanatomical tracing techniques. J Anat 127:425-441.
69. Waszczak BL, Bergstrom DA, Walters JR (1981) Single unit responses of substantia nigra and globus pallidus neurons to GABA agonist and antagonist drugs. Adv Biochem Psychopharmacol 30:79-94.
70. Westerink BH, Hofsteede HM, Damsma G, de Vries JB (1988) The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol 337:373-378.
71. Westerink BH, Teisman A, de Vries JB (1994) Increase in dopamine release from the nucleus accumbens in response to feeding: a model to study interactions between drugs and naturally activated dopaminergic neurons in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 349:230-235.
72. Wiedemann DJ, Garris PA, Near JA, Wightman M (1992) Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum. J Pharmacol Exp Ther 261:574-579.
73. Wilson C, Nomikos GG, Collu M, Fibiger HC (1995) Dopaminergic correlates of motivated behavior: importance of drive. J Neurosci 15:5169-5178.
74. Yamamoto BK, Cooperman MA (1994) Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J Neurosci 14:4159-4166.
75. Yoshida M, Yokoo H, Tanaka T, Emoto H, Tanaka M (1994) Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res 636:111-114.
76. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13:290-296.